Membrane type 1 matrix metalloproteinase regulates anaplastic thyroid carcinoma cell growth and invasion into the collagen matrix

基质金属蛋白酶 间质细胞 癌症研究 细胞生长 金属蛋白酶 甲状腺癌 病理 癌症 生物 医学 内科学 生物化学
作者
Tsutomu Yoshida,Nobuyasu Suganuma,Shinya Sato,Soji Toda,Hirotaka Nakayama,Katsuhiko Masudo,Yoichiro Okubo,Hiroyuki Hayashi,Tomoyuki Yokose,Naohiko Koshikawa,Yasushi Rino,Hiroyuki Iwasaki,Yohei Miyagi,Munetaka Masuda,Daisuke Hoshino
出处
期刊:Biochemical and Biophysical Research Communications [Elsevier BV]
卷期号:529 (4): 1195-1200 被引量:5
标识
DOI:10.1016/j.bbrc.2020.06.043
摘要

Anaplastic thyroid carcinoma (ATC) is one of the most aggressive cancer types; however, the molecular mechanism contributing to the aggressive characteristics remain unclear. Membrane type 1 matrix metalloproteinase (MT1-MMP) plays an important role in cancer invasion and has been associated with a poor prognosis in various malignant neoplasms. In this study, we investigated the relationship between MT1-MMP expression and the proliferation and invasion of ATC cells, along with the association with clinicopathologic factors in patients with ATC. Suppression of MT1-MMP reduced the proliferation and invasion of ATC cells, and suppressed ERK activity, indicating a role in cancer cell proliferation in collagen matrix culture conditions. The expression of MT1-MMP was detected in 29 of 34 (85.3%) surgical specimens from ATC patients. In addition, the expression of MT1-MMP in the tumor lesion was higher than that of normal and stromal tissues. Collectively, these results suggest that elevated MT1-MMP expression plays a role in the pathogenesis of ATC, which may promote its aggressive characteristics such as proliferation and invasion, highlighting a potential new therapeutic target.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
摸俞发布了新的文献求助10
刚刚
刚刚
1秒前
3秒前
稳重誉完成签到,获得积分20
3秒前
玄黄大世界完成签到,获得积分10
3秒前
4u完成签到,获得积分20
4秒前
4秒前
丰富寄翠发布了新的文献求助10
5秒前
溯7发布了新的文献求助10
7秒前
7秒前
大模型应助零食宝采纳,获得10
8秒前
biuxuni发布了新的文献求助28
8秒前
二光头发布了新的文献求助10
8秒前
123完成签到,获得积分10
9秒前
cr7发布了新的文献求助10
9秒前
10秒前
CBY发布了新的文献求助10
10秒前
10秒前
XJM发布了新的文献求助20
10秒前
英吉利25发布了新的文献求助10
12秒前
13秒前
13秒前
明理薯片完成签到,获得积分10
13秒前
Zilaap完成签到,获得积分10
14秒前
14秒前
科研通AI6.2应助KingYugene采纳,获得10
14秒前
小鹿完成签到 ,获得积分10
15秒前
cc完成签到,获得积分20
15秒前
16秒前
SciGPT应助二光头采纳,获得10
16秒前
科研通AI6.3应助11采纳,获得10
16秒前
16秒前
fire完成签到 ,获得积分10
17秒前
CBY完成签到,获得积分10
17秒前
patato1101完成签到,获得积分10
17秒前
17秒前
wty完成签到,获得积分10
19秒前
20秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6963121
求助须知:如何正确求助?哪些是违规求助? 8645234
关于积分的说明 18335410
捐赠科研通 6413186
什么是DOI,文献DOI怎么找? 3086646
关于科研通互助平台的介绍 2135812
邀请新用户注册赠送积分活动 2063091